Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Horn

Showing results (421-430 of 463) with videos related to

Pageof 47
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialA S Mansfield, A Każarnowicz, N Karaseva, et al.
American Journal of Epidemiology|January 11, 2007
Diet and risk of ovarian cancer in the California Teachers Study cohortEllen T Chang, Valerie S Lee, Alison J Canchola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2017
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trialR Hui, E B Garon, J W Goldman, et al.
Journal of Epidemiology and Community Health|April 8, 2016
Strategies for recruiting representative samples of Asian Americans for a population-based case-control studyCeleste K Wong, Pamela L Horn-Ross, Gilbert C Gee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancerD E Gerber, L Horn, M Boyer, et al.
Population Health Management|November 20, 2020
Relationship of Clinician Care Team Composition and Diabetes Quality OutcomesBenjamin D Meyerink, Michelle A Lampman, Susan B Laabs, et al.
Cancer Causes & Control : CCC|December 23, 2006
Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohortEllen T Chang, Alison J Canchola, Valerie S Lee, et al.
Toxicology|April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistThomas L Horn, J Brooks Harder, William D Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasisPeter G Pappas, Coleman M F Rotstein, Robert F Betts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331<sup>☆</sup>D R Spigel, D Vicente, T E Ciuleanu, et al.
Pageof 47

Showing results (421-430 of 463) with videos related to

Sort By:
Pageof 47
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialA S Mansfield, A Każarnowicz, N Karaseva, et al.
American Journal of Epidemiology|January 11, 2007
Diet and risk of ovarian cancer in the California Teachers Study cohortEllen T Chang, Valerie S Lee, Alison J Canchola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2017
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trialR Hui, E B Garon, J W Goldman, et al.
Journal of Epidemiology and Community Health|April 8, 2016
Strategies for recruiting representative samples of Asian Americans for a population-based case-control studyCeleste K Wong, Pamela L Horn-Ross, Gilbert C Gee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancerD E Gerber, L Horn, M Boyer, et al.
Population Health Management|November 20, 2020
Relationship of Clinician Care Team Composition and Diabetes Quality OutcomesBenjamin D Meyerink, Michelle A Lampman, Susan B Laabs, et al.
Cancer Causes & Control : CCC|December 23, 2006
Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohortEllen T Chang, Alison J Canchola, Valerie S Lee, et al.
Toxicology|April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistThomas L Horn, J Brooks Harder, William D Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasisPeter G Pappas, Coleman M F Rotstein, Robert F Betts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2021
Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331<sup>☆</sup>D R Spigel, D Vicente, T E Ciuleanu, et al.
Pageof 47